CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.5B
AUM Growth
+$14.5B
(+2.7%)
Cap. Flow
+$373M
Cap. Flow
% of AUM
2.58%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
738
New
61
Increased
262
Reduced
284
Closed
31
Top Buys
| 1 |
Visa
V
|
$77.8M |
| 2 |
Gilead Sciences
GILD
|
$59.3M |
| 3 |
Microsoft
MSFT
|
$46.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$40.2M |
| 5 |
Nu Holdings
NU
|
$39.1M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$112M |
| 2 |
Royal Bank of Canada
RY
|
$51.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$42.8M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.9M |
| 5 |
Merck
MRK
|
$33.3M |
Sector Composition
| 1 | Technology | 30.32% |
| 2 | Healthcare | 28.88% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.52% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Otis Worldwide
OTIS
$33.6B
| $25.5M | 0.18% |
285,010
-36,698
| -11% | -$3.28M |
|
127
Pfizer
PFE
$141B
| $25.4M | 0.18% |
881,791
+180,002
| +26% | +$5.18M |
|
128
Fiserv
FI
$74.3B
| $25.2M | 0.17% |
189,960
+2,117
| +1% | +$281K |
|
129
DexCom
DXCM
$30.9B
| $25.2M | 0.17% |
203,096
-116,247
| -36% | -$14.4M |
|
130
CME Group
CME
$97.1B
| $24.9M | 0.17% |
118,352
+92,918
| +365% | +$19.6M |
|
131
Crown Holdings
CCK
$10.7B
| $24.7M | 0.17% |
268,246
+116,387
| +77% | +$10.7M |
|
132
Xenon Pharmaceuticals
XENE
$2.99B
| $24.5M | 0.17% |
530,884
-39,000
| -7% | -$1.8M |
|
133
Mettler-Toledo International
MTD
$26.1B
| $24.3M | 0.17% |
20,025
-416
| -2% | -$505K |
|
134
Host Hotels & Resorts
HST
$11.8B
| $24.2M | 0.17% |
1,241,042
-160,467
| -11% | -$3.12M |
|
135
Advanced Drainage Systems
WMS
$11B
| $24M | 0.17% |
170,466
-134,216
| -44% | -$18.9M |
|
136
United Rentals
URI
$60.8B
| $23.7M | 0.16% |
41,311
-9,642
| -19% | -$5.53M |
|
137
Elevance Health
ELV
$72.4B
| $23.6M | 0.16% |
50,088
+1,068
| +2% | +$504K |
|
138
IBM
IBM
$227B
| $23.6M | 0.16% |
144,334
+1,343
| +0.9% | +$220K |
|
139
Exxon Mobil
XOM
$477B
| $23.4M | 0.16% |
234,460
-29,058
| -11% | -$2.91M |
|
140
Silicon Laboratories
SLAB
$4.3B
| $23.4M | 0.16% |
176,863
+11,773
| +7% | +$1.56M |
|
141
Lamb Weston
LW
$7.88B
| $23.4M | 0.16% |
216,233
+23,398
| +12% | +$2.53M |
|
142
Progressive
PGR
$145B
| $23.3M | 0.16% |
146,580
-28,392
| -16% | -$4.52M |
|
143
Ameriprise Financial
AMP
$47.8B
| $23.3M | 0.16% |
61,365
+40,040
| +188% | +$15.2M |
|
144
Sempra
SRE
$53.7B
| $23.2M | 0.16% |
310,188
+1,900
| +0.6% | +$142K |
|
145
Bank of Montreal
BMO
$88.5B
| $23.1M | 0.16% |
231,815
+137,898
| +147% | +$13.7M |
|
146
Estee Lauder
EL
$33.1B
| $22.5M | 0.16% |
154,154
+31,939
| +26% | +$4.67M |
|
147
Becton Dickinson
BDX
$54.3B
| $22.5M | 0.16% |
92,427
-8,641
| -9% | -$2.11M |
|
148
Cytokinetics
CYTK
$5.98B
| $22.3M | 0.15% |
267,240
-236,000
| -47% | -$19.7M |
|
149
McKesson
MCK
$85.9B
| $22.3M | 0.15% |
48,172
+11,081
| +30% | +$5.13M |
|
150
Deckers Outdoor
DECK
$18.3B
| $22.1M | 0.15% |
+198,264
| New | +$22.1M |
|